Hill-Rom Holdings Inc

Hill-Rom — Merger or Acquisition (June 2015)

14 slides from Hill-Rom's merger presentation, Jun 17, 2015

  1. Slide 1: Creating a Global Leader in Patient Care Solutions

    Slide 1: Creating a Global Leader in Patient Care Solutions

    June 17, 2015 Creating a Global Leader in Patient Care Solutions

  2. Slide 2: Forward Looking Statements

    Slide 2: Forward Looking Statements

    Certain statements in this presentation contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding the Company’s future plans, objectives, beliefs, expectations, representations and projections. It is important to note that forward-looki

  3. Slide 3: Additional Information and Where to Find It

    Slide 3: Additional Information and Where to Find It

    Hill-Rom will file with the Securities and Exchange Commission (the “SEC”) a registration statement on Form S-4 to register shares of Hill-Rom common stock that will be issued to Welch Allyn shareholders in connection with the transaction, which will include a proxy statement/prospectus that will be

  4. Slide 4: Speakers on Today's Call

    Slide 4: Speakers on Today's Call

    John J. GreischPresident and CEOHill-Rom Holdings, Inc. Steven J. StrobelSVP and CFOHill-Rom Holdings, Inc. Speakers on Today’s Call

  5. Slide 5: Transaction Highlights

    Slide 5: Transaction Highlights

    Acquisition of Welch Allyn significantly accelerates Hill-Rom’s strategyCompelling financial profile and cash generation for the combined entityOver 10% accretive to FY16 Adjusted EPS, and meaningfully higher thereafter, and immediately accretive to Adjusted Gross and EBITDA marginsBuilds meaningful

  6. Slide 6: Acquisition of Welch Allyn Accelerates Hill-Rom's Strategy

    Slide 6: Acquisition of Welch Allyn Accelerates Hill-Rom's Strategy

    Acquisition of Welch Allyn Accelerates Hill-Rom’s Strategy Adds market leading positions in patient safety, caregiver efficiency, and point of care diagnostics and testingProvides significant scale which enhances relevance to customers and strengthens combined competitive positionCombined company wi

  7. Slide 7: Combined Leadership Across Care Settings

    Slide 7: Combined Leadership Across Care Settings

    Combined Leadership Across Care Settings From office exam, through hospital admission, treatment and recovery, and into post-acute care Primary Care/ Ambulatory ER ICU and Patient Room Bringing scale and portfolio depth to our customers Post-Acute OR

  8. Slide 8: Welch Allyn Overview

    Slide 8: Welch Allyn Overview

    Welch Allyn Overview Financial Overview Revenue Breakdown Annual Revenue ~$700 million Gross Margin > 50% Adjusted EBITDA > 20% N.A. Asia Pacific/Other EMEA Hospitals Primary Care/Ambulatory A market leader with an attractive business model Key Product Categories Physical AssessmentVital Signs Monit

  9. Slide 9: Diversified Platform to Drive Growth

    Slide 9: Diversified Platform to Drive Growth

    Diversified Platform to Drive GrowthPro Forma* Full Year FY15 Revenue of ~$2.6 Billion Pro Forma Revenue by Geography Accelerates Hill-Rom’s portfolio diversificationand expands international footprint N.A. Europe EmergingMarkets/Other Pro Forma Revenue by Category Acute CareCapital Service/Other Su

  10. Slide 10: Transaction Overview

    Slide 10: Transaction Overview

    Transaction Overview $2.05 billion including $1.625 of cash and approximately 8.1 million of newly issued shares of Hill-Rom stockWelch Allyn shareholders will own approximately 13% of combined company; no single shareholder will own more than approximately one percent Consideration Committed financ

  11. Slide 11: Compelling Financial Benefits

    Slide 11: Compelling Financial Benefits

    Compelling Financial Benefits Strong value creating acquisition Combined company will have approximately $2.6 billion in revenue and over $500 million of Adjusted EBITDA after cost synergy benefits are fully realizedExpected accretion of approximately 200 bps to FY15 Hill-Rom Adjusted Gross and EBIT

  12. Slide 12: Reaffirming Hill-Rom's Financial Guidance

    Slide 12: Reaffirming Hill-Rom's Financial Guidance

    Reaffirming financial expectations provided on May 5, 2015Third quarter fiscal 2015*Reported revenue growth of 13 to 15 percentAdjusted Earnings per Diluted Share expected to be $0.58 to $0.61Full year fiscal 2015*Reported revenue growth of 10 to 11 percentAdjusted Earnings per Diluted Share expecte

  13. Slide 13: Next Steps

    Slide 13: Next Steps

    Next Steps Closing expected before September 30, 2015Integration planning will be led by Hill-Rom Chief Operating Officer, Carlyn SolomonTeam will include senior members of both Hill-Rom and Welch AllynWelch Allyn leadership structure will include members of both organizationsConfident in our abilit

  14. Slide 14: Acquisition Summary

    Slide 14: Acquisition Summary

    Acquisition Summary Strengthens combined company’s global competitive positions Creates a comprehensive portfolio of innovative, patient care focused solutions with enhanced cross-selling opportunitiesAccelerates Hill-Rom’s transformational strategy with the addition of margin accretive revenue grow

Source: SEC EDGAR · 425 filed Jun 17, 2015

More decks from Hill-Rom Holdings Inc